Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials. | Clin Microbiol Infect;2022 Oct 17. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials.

Gallagher, Jason C; Morgan, Rebecca L.

Gallagher JC; Temple University, School of Pharmacy, Philadelphia, Pennsylvania, USA. Electronic address: jason.gallagher@temple.edu.
Morgan RL; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Clin Microbiol Infect ; 2022 Oct 17.

Article in English | MEDLINE | ID: covidwho-2240834

Keywords

Baricitinib; COVID-19; IL6 inhibitor; Sarilumab; Tocilizumab

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article